Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.
Xinguang WangZhaoqing FanXing WangYingjian HeYiqiang LiuXiang WangBailin ZhangZefei JiangTao WangZhigang YuFei WangYinhua LiuYanping LiJianguo ZhangBin LuoHongchuan JiangTianfeng WangYuntao XieJinfeng LiTao OuyangPublished in: Breast cancer research and treatment (2022)
NCT01613560.